pharmaceutical – media

Pharmaceutical exports; how to approach marketing research

Identifying the right clients is a common challenge when it comes to product exporting issues. This is why well-organized marketing research which is precise and reliable can be the key to assist you to work out a clear working plan.
- Source: Ddu
- 1,196
- August 17, 2018
market research pharmaceutical Researches
Aerie Extends Drug-Delivery Tech Contract with DSM Biomedical

The extended deal with DSM offers Aerie an elite worldwide license to DSM’s polyesteramide polymer technology for a limitless number of drugs in any ophthalmic indication and also an exposure to DSM’s preclinical latanoprost implant created for people with glaucoma. The two companies have spanned their partnership till the end of 2020, as per Aerie.
- Source: DrugDeliveryBusiness
- 1,000
- August 3, 2018
Company Insight digital health glaucoma pharmaceutical
Filing Lawsuit Against Drugmakers for Funding Terrorism

Last year, around 100 veterans filed a bombshell lawsuit against several drugmakers, by accusing that they funded terrorism by paying high bribes to win contracts with the Iraqi Ministry of Health. At present, the Department of Justice is investigating similar accusations, as per AstraZeneca securities filing which says that it's part of the probe.
- Source: FiercePharma
- 1,044
- August 3, 2018
AstraZeneca Company Insight pharmaceutical
Nebraska Informs Pfizer to Prosecute Over Lethal Injection

Pfizer objected to the use of its drugs for lethal injection procedures last year by asking states to return the drugs immediately for a refund. But not all of them have halted its utilization. Hence, with an execution planned in Nebraska dated Aug. 14, a state senator is urging Pfizer to prosecute if the drug usage is not halted.
- Source: FiercePharma
- 956
- August 1, 2018
Company Insight Pfizer pharmaceutical
Mircera Gets FDA Nod For CKD-Related Drug

The recent research that achieved the FDA approval for Mircera, had 64 patients, aged between 5 to 17 years old who suffered from chronic kidney disease (CKD) and were on kidney dialysis at the beginning of the study.
- Source: MedPage Today
- 1,158
- June 13, 2018
chronic kidney disease New Approvals pharmaceutical
Wasdell Half-Million Investment For Lab Expansion

The UK Based, Wasdell Group a leading service provider for the pharma and medical industries, is planning to invest $671,000 to support its pharma manufacturing through a laboratory project; before the end of this year, the company is also planning to move into sterile manufacturing.
- Source: Fierce Pharma
- 1,097
- June 11, 2018
Company Insight pharmaceutical
New rapid Rabies test- LN34; developed by U.S Center for Disease Control

Rabies takes nearly 60,000 lives each year; it is deadly if not treated early. Regions like Africa and Asia are at higher risk. LN34 is believed to make screening faster and better test to avoid the weeks-long series of shots now given to prevent the disease for the people exposed to potentially rabid. The test, done on suspect animals, can be run on platforms which are already used to screen for the flu, tuberculosis, and HIV.
- Source: Ddu
- 932
- May 18, 2018
New Approvals pharmaceutical rabies
AbbVie pressurized to keep low price for Imbruvica formula

This year AbbVie launched Imbruvica, a single tablet for blood cancer treatment. It has been designed as a convenient therapy measure for patients who used the old tablets as often as four times a day. Adapting the new single tablet in their treatment regimens will prove to be an expensive proposition for some patients as the new tablet comes with a price tag of $400 each, triple the cost of the older tablets.
- Source: Ddu
- 1,108
- May 17, 2018
AbbVie Company Insight pharma pharmaceutical
Ddu’s International Medical Exhibition Attendance Delivering High Results.

Ddu, the leading global pharmaceutical & medical device B2B online platform, is currently attending global exhibitions, leaving its footprints at multiple word-class medical trade shows in South Korea, India, Chongqing (China), Turkey and the United States.
- Source: Ddu
- 49,762
- April 9, 2018
Exhibitions & Activities medical device pharmaceutical
Big Events on Pharmaceuticals during NPC & CPPCC

The two sessions (NPC & CPPCC) this year have received much attention from China and outside China, wherein, the most-watched theme is “reform”. Regarding pharmaceuticals, the event that attracts the highest attention is CFDA reform, followed by policy moves of the TCM issue and bio-medicine, etc. that China has been strongly supporting in recent years.
- Source: EN-CPhI
- 1,121
- March 26, 2018
CFDA China CPhI pharmaceutical Policies

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.